A Weill Cornell Medicine research team will receive $1.3 million over five years to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.
Wegmans is set to open this Sunday at the Brooklyn Navy Yard in New York City. Edward McLaughlin, emeritus professor of food industry management, says given Wegmans’ supermarket innovation in service and products, New York City will now be able to relish in the legendary service, restaurant-quality prepared foods and wide selection of goods that are the envy of supermarket companies around the globe.
The third annual Cornell High School Programming Contest Warm Up, a virtual computer programming competition, was less a contest and more a chance for budding programmers to hone their skills.
Three Cornell faculty members and a senior lecturer have been recognized with Kendall S. Carpenter Memorial Advising Awards for their sustained and distinguished contributions.
Weill Cornell Medicine’s debt-reduction program was created in 2019 to cover tuition, fees, housing and living expenses for students with financial need.
Enforcement of New York City’s vaccine mandate for uniformed service providers begins today. Lee Adler says the city’s uniformed service providers are potentially risking reputational damage and the high number of unvaccinated firefighters will likely result in service limitations.
The seventh episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features Laura Ciccone ‘11 and Taly Matiteyahu, co-founders of Blink, a voice-first blind speed dating app that helps people build meaningful connections based on genuine compatibility.
Cornell Tech’s first virtual Open Studio – an end-of-semester event in which students present the products they built to members of the tech industry – will be held online May 15.
Researchers found that they could use an existing experimental drug to slow metabolism of certain aggressive B-cell lymphomas in lab-dish and animal studies.
Wolchok, an internationally acclaimed medical oncologist, will lead a clinical enterprise dedicated to translating groundbreaking discoveries on the underlying causes of cancer into cutting-edge treatment approaches and personalized therapies to improve patient outcomes.
